Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

UK BROKER RATINGS: Citigroup Upgrades AstraZeneca To Buy

22nd Apr 2014 09:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning: ---------- FTSE 100 ---------- GOLDMAN CUTS ARM PRICE TARGET TO 1450 (1500) PENCE - 'BUY' ---------- HSBC CUTS BARCLAYS PRICE TARGET TO 285 (315) P Read More

UK MORNING BRIEFING: Glaxo And AstraZeneca Put M&A In Focus

22nd Apr 2014 07:39

LONDON (Alliance News) - UK shares have opened slightly higher Tuesday following gains on Wall Street over the long Easter weekend. Merger and acquisition activity and discussion surrounding UK pharmaceutical giants GlaxoSmithKline and AstraZeneca Read More

MARKET COMMENT: UK Stocks To Open Slightly Higher With M&A In Focus

22nd Apr 2014 06:41

LONDON (Alliance News) - UK stocks are set to open marginally higher Tuesday, as European markets play catch-up with Wall Street, which made gains over the long Easter weekend despite ongoing tensions in Ukraine. Spreadbetters are indicating that the FTSE 100 will open slightly higher Tuesd Read More

PRESS: Pfizer Makes USD100 Bln Bid For AstraZeneca - Reports

22nd Apr 2014 05:27

LONDON (Alliance News) - US pharmaceutical giant Pfizer Inc. offered to acquire rival UK drugmaker AstraZeneca PLC for USD101 billion, or 60 billion pounds, according to media reports. The Sunday Times reported the takeover news citing some senior investment bankers and industry sources. Th Read More

UK AGM, EGM Calendar - Week Ahead

22nd Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

22nd Apr 2014 05:12

UK AGM, EGM Calendar - Week Ahead

17th Apr 2014 15:19

UK Earnings, Trading Statements Calendar - Week Ahead

17th Apr 2014 15:19

UK BROKER RATINGS: UBS Cuts Ashmore Rating, Raises Schroders Price Target

14th Apr 2014 09:10

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- UBS REMOVED SCHRODERS FROM LEAST PREFERRED LIST ---------- UBS RAISES SCHRODERS PRICE TARGET TO 2700 (2650) PENCE - 'NEUTRAL' Read More

Hutchison China MediTech Begins Colorectal Cancer Trial

4th Apr 2014 09:25

LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its majority-owned research and development company Hutchison MediPharma Ltd has initiated a Phase II clinical trial in colorectal cancer patients in China for fruquintinib. Fruquintinib is the company's investigational small Read More

UK BROKER RATINGS: Jefferies Raises REIT Price Targets

1st Apr 2014 09:11

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning: ---------- FTSE 100 ---------- GOLDMAN RAISES INTL AIRLINES GROUP (IAG) PRICE TARGET TO 430 (420) PENCE - 'NEUTRAL' ---------- BARCLAYS CUTS PRUDEN Read More

DIRECTOR DEALINGS: AstraZeneca Non-Executive Director Buys Shares

26th Mar 2014 11:33

LONDON (Alliance News) - AstraZeneca PLC Wednesday said Non-Executive Director Geneviève Berger bought 460 shares at a price of 3,896 pence a share Tuesday. Following this transaction, Berger holds 1,790 shares. Shares in the biopharmaceutical company were trading at 3,903.00p, up 0.3 Read More

UK Dividends Calendar - Week Ahead

24th Mar 2014 06:42

UK Dividends Calendar - Week Ahead

21st Mar 2014 16:11

UK Dividends Calendar - Week Ahead

21st Mar 2014 06:13

UK Dividends Calendar - Week Ahead

20th Mar 2014 16:02

UK Dividends Calendar - Week Ahead

20th Mar 2014 06:33

UK Dividends Calendar - Week Ahead

19th Mar 2014 16:42

DIRECTOR DEALINGS: AstraZeneca Non-Executive Buys Shares

19th Mar 2014 15:10

LONDON (Alliance News) - AstraZeneca PLC Wednesday said non-executive Director Geneviève Berger bought 430 shares at a price of 3,955 pence a share Tuesday. Following this transaction, Berger holds 1,330 shares. Shares in the biopharmaceutical company were trading at 3,996.00p up 0.4% Read More

AstraZeneca Unveils Nexium Direct-to-Patient Program

19th Mar 2014 12:34

LONDON (Alliance News) - AstraZeneca said it launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home. Nexium Direct is part of AstraZeneca Direct, a web-based offering that delivers select brand name prescription me Read More

FTSE 100 Latest

Value10,600.53

Change-2.95